One vaccine. One dose. One visit.
One dose of Prevnar 20Ⓡ provides lasting protection against 20 strains of the bacteria that cause both pneumococcal pneumonia and invasive pneumococcal disease, like meningitis or blood infection.*
*Based on a clinical study for Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) showing protection for approximately 4 years. Prevnar 20 and Prevnar 13 are manufactured and formulated similarly and contain 13 of the same polysaccharide conjugates.
CDC recommended for adults 50+
If you’re 50 or older, the CDC recommends that you get vaccinated to help protect yourself against pneumococcal pneumonia and invasive pneumococcal disease.
Talk to your doctor to see if Prevnar 20 is right for you.
Pneumococcal pneumonia and invasive pneumococcal disease can strike in any season.
Pneumococcal disease can be serious and could put you in the hospital. Prevnar 20 can help protect eligible adults against 20 different strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease.
You may be at increased risk if you are:
19 or older with certain chronic conditions
Conditions include diabetes, asthma, COPD, chronic heart disease, and chronic kidney failure.
Adults taking certain medicines
that suppress the immune system
are also at increased risk.
CDC=Centers for Disease Control and Prevention; COPD=chronic obstructive pulmonary disease.
Prevnar† vaccines have a demonstrated safety profile and have been given to approximately 75 million‡ adults in the US over 10 years.
†Prevnar vaccines include Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) and Prevnar 20. In the US, Prevnar 13 was available for adults from 2012 to 2024.
‡Based on information licensed from IQVIA: Longitudinal prescription and medical claims data from January 2014 to March 2025, reflecting estimates of real-world activity. IQVIA® is a registered trademark of IQVIA Inc. All rights reserved.